Drug Repackagers Could Be Liable For Medicaid Rebates Due To Pending FDA Rule
Executive Summary
BOSTON - Drug wholesalers that repackage drugs may face responsibilities for paying Medicaid drug rebates, should an FDA rule on relabeling be made final